Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By Staff Reporters
***
***
A new device could make drug trials safer
Northwestern University scientists have developed a smaller-than-a-shoebox contraption that can simulate how the human body reacts to various diseases or medications. This technology could be used as an additional fail-safe check in clinical trials between the animal and human testing stages. The device makes it easier for scientists to understand how diseases and drugs affect the body because it can simulate the effects of up to eight different organ tissue samples at once for as long as 28 days.
It’s a big step up from current drug-simulating lab systems, which can only accommodate two tissue cultures that don’t last for very long.
COMMENTS APPRECIATED
Thank You
***
***
Share this:
Filed under: Drugs and Pharma, Ethics | Tagged: clinical drug trials, clinical trials, drug trials, Drugs, pharma, phase 4 | Leave a comment »
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 